This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
3D Osteochondral Model
Special Programs
A new dimension in testing

An osteochondral model has been developed using a 3D scaffold to create a defined bi-layer construct (Figure 1A). Bioprinted mesenchymal stem cells (MSCs) are differentiated in the 3D environment to mature into chondrocytes (Figure 1C). Osteochondral co-cultures are then created bioprinting MSC derived osteoblasts onto the bioprinted chondrocyte layer (Figure 1B). The mature model can be stimulated and respond to inflammatory cytokines, resulting in a loss of chondral layer proteoglycan content specifically aggrecan (Figure 1D).
Furthermore the osteochondral co-cultures present an osteoarthritis like phenotype with release of disease associated proteins such as matrix metalloprotease-9 (MMP9), MMP13 and a disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAMTS4) into co-culture supernatant (Figure 2). The disease like phenotype also results in the general increase of MMP activity as shown in Figure 3. This response can be modified through treatment of models with molecules such as a pan metalloprotease inhibitor.
Furthermore the osteochondral co-cultures present an osteoarthritis like phenotype with release of disease associated proteins such as matrix metalloprotease-9 (MMP9), MMP13 and a disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAMTS4) into co-culture supernatant (Figure 2). The disease like phenotype also results in the general increase of MMP activity as shown in Figure 3. This response can be modified through treatment of models with molecules such as a pan metalloprotease inhibitor.